Please assess the completion status of the following clinical trial:

Trial Title: Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* stroke~* lesion age at least 6 months~* aphasia with at least moderate severity according to Aachener Aphasia Test (AAT)~* age between 40 and 75~* German-speaking (at a native speaking level)~Exclusion Criteria:~* cognitive or speech-language therapy during the 2-weeks stimulation course~* intensive language training when exceeding 1 hour, 2 times a week during the 2-weeks stimulation course and the follow-up period (60 days after stimulation was completed)~* additional neurological diseases, e.g. surgical brain tumor removal, untreated tumor disease, acute traumatic brain injury, and/or craniotomy~* (severe) dysarthria~* untreated hypertension exceeding 160/100 mmHg (patients with treated hypertension and blood pressure below 160/100 mmHg can be included)~* increased risk of vascular thrombosis~* epilepsy, photo sensitivity, acute focal findings (patients without focal findings or epileptiform discharges can be included when they had only a single seizure more than 10 years ago)~* dementias and neurodegenerative diseases~* significant psychiatric disturbances, e.g. schizophrenia~* major attention and/or memory deficits~* major hearing loss~* patients with uncorrected visual deficits~* severe global aphasia~* modality-specific disorders (pure speech apraxia, pure alexia, pure agraphia)~* electric or electronic implants (e.g. heart pacemakers)~* metal artefacts located at the head~* medication with impact on the central nervous system (e.g. antidepressant or sedative drugs)~* participation in another trial~* pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Verum stimulation (Type: EXPERIMENTAL): repetitive transorbital alternating current stimulation (rtACS)
- Placebo stimulation (Type: SHAM_COMPARATOR): Sham stimulation (placebo condition) no intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).